|
?:authorAffiliation
|
-
[\'Department of Epidemiology and Biostatistics School of Public Health Imperial College London London UK.\', \'Dementia Research Institute at Imperial College London London UK.\', \'Institute of Cardiovascular and Medical SciencesUniversity of Glasgow UK.\', \'Center for Genomic Medicine Massachusetts General Hospital Boston MA.\', \'McCance Center for Brain Health Massachusetts General Hospital Boston MA.\', \'Program in Medical and Population Genetics Broad Institute of MIT and Harvard Cambridge MA.\', \'Department of Medical Genetics School of Clinical Medicine University of Cambridge UK.\', \'The Alan Turing Institute London UK.\', \'Medical Research Council Biostatistics Unit University of Cambridge UK.\', \'Stroke Pharmacogenomics and Genetics Group Biomedical Research Institute Sant Pau Spain.\', \'Department of Public Health and Primary Care Cardiovascular Epidemiology Unit University of Cambridge UK.\', \'Department of Neurology Brigham and Women\'s Hospital Boston MA.\', \'Clinical Pharmacology and Therapeutics Section Institute of Medical and Biomedical Education and Institute for Infection and ImmunitySt George\'sUniversity of London London UK.\', \'Clinical Pharmacology Group, Pharmacy and Medicines Directorate St George\'s University Hospitals NHS Foundation Trust London UK.\', \'Novo Nordisk Research Centre Oxford Oxford UK.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}